🔎 Trials Near Me

Dachaigh › Obesity › Connecticut

Sgrùdaidhean clionaigeach Obesity ann an Connecticut

Tha 22 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann an Connecticut.

Bailtean ann an Connecticut

Teacsa sgrùdaidh oifigeil (Beurla)

Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles

  • University of Connecticut, Storrs
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07844616

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Yale School of Medicine - Yale Diabetes Center (YDC)) Trials, New Haven
  • Stamford Therapeutics Consortium, Stamford
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • New England Research Associates, LLC, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • New England Research Associates, LLC, Bridgeport
  • Yale University School of Medicine, New Haven
  • Chase Medical Research, LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Chase Medical Research, LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Stamford Therapeutics Consortium, Stamford
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Cardiology Associates of Fairfield County PC, Stamford
A’ fastadhÌre 3
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Yale University, New Haven
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Waterbury
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Stamford Therapeutics Consortium, Stamford
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Stamford
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Chase Medical Research LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Bridgeport
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

  • Kailera Clinical Site, Hamden
  • Kailera Clinical Site, Stamford
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07284979

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Chase Medical Research LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07509307

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

  • UConn Health, Farmington
  • Hartford HealthCare, Hartford
  • University of Connecticut, Storrs
A’ fastadh
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07238556

Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery

  • Hartford HealthCare, Hartford
A’ fastadh
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06484621

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

  • Yale Pediatric Diabetes Center, Adult and Children's Progam, New Haven
A’ fastadhÌre 2
Aoisean 18 gu 30 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06411210

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Chase Medical Research LLC, Hamden
  • Chase Medical Research LLC, Waterbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07481630

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

  • Yale University, New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT07376655

New Mechanisms of Obesity

  • Yale University, New Haven
A’ fastadh
Aoisean 15 gu 22 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT06768827

Craving Network Neurofeedback

  • Yale MRRC Anlyan Center, New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 3 Dùbh 2025 · NCT06426693

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.